21 CFR Subpart C - Subpart C—Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
prev | next
- § 516.111 Scope of this subpart.
- § 516.115 Definitions.
- § 516.117 Submission of correspondence under this subpart.
- § 516.119 Permanent-resident U.S. agent for foreign requestors and holders.
- § 516.121 Meetings.
- § 516.123 Informal conferences regarding agency administrative actions.
- § 516.125 Investigational use of minor species new animal drugs to support indexing.
- § 516.129 Content and format of a request for determination of eligibility for indexing.
- § 516.131 Refuse to file a request for determination of eligibility for indexing.
- § 516.133 Denying a request for determination of eligibility for indexing.
- § 516.135 Granting a request for determination of eligibility for indexing.
- § 516.137 Notification of decision regarding eligibility for indexing.
- § 516.141 Qualified expert panels.
- § 516.143 Written report.
- § 516.145 Content and format of a request for addition to the index.
- § 516.147 Refuse to file a request for addition to the index.
- § 516.149 Denying a request for addition to the index.
- § 516.151 Granting a request for addition to the index.
- § 516.153 Notification of decision regarding index listing.
- § 516.155 Labeling of indexed drugs.
- § 516.157 Publication of the index and content of an index listing.
- § 516.161 Modifications to indexed drugs.
- § 516.163 Change in ownership of an index file.
- § 516.165 Records and reports.
- § 516.167 Removal from the index.
- § 516.171 Confidentiality of data and information in an index file.
Source:
72 FR 69121, Dec. 6, 2007, unless otherwise noted.